• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康与疾病中的α-突触核蛋白蛋白水解。

Proteolytic α-Synuclein Cleavage in Health and Disease.

机构信息

Flechsig Institute for Brain Research, University of Leipzig, 04103 Leipzig, Germany.

Department for Experimental Therapy, University Clinics Erlangen and Preclinical Experimental Center, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.

出版信息

Int J Mol Sci. 2021 May 21;22(11):5450. doi: 10.3390/ijms22115450.

DOI:10.3390/ijms22115450
PMID:34064208
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8196865/
Abstract

In Parkinson's disease, aggregates of α-synuclein within Lewy bodies and Lewy neurites represent neuropathological hallmarks. However, the cellular and molecular mechanisms triggering oligomeric and fibrillary α-synuclein aggregation are not fully understood. Recent evidence indicates that oxidative stress induced by metal ions and post-translational modifications such as phosphorylation, ubiquitination, nitration, glycation, and SUMOylation affect α-synuclein conformation along with its aggregation propensity and neurotoxic profiles. In addition, proteolytic cleavage of α-synuclein by specific proteases results in the formation of a broad spectrum of fragments with consecutively altered and not fully understood physiological and/or pathological properties. In the present review, we summarize the current knowledge on proteolytical α-synuclein cleavage by neurosin, calpain-1, cathepsin D, and matrix metalloproteinase-3 in health and disease. We also shed light on the contribution of the same enzymes to proteolytical processing of pathogenic proteins in Alzheimer's disease and report potential cross-disease mechanisms of pathogenic protein aggregation.

摘要

在帕金森病中,α-突触核蛋白在路易小体和路易神经突内的聚集代表了神经病理学的特征。然而,触发寡聚体和纤维状α-突触核蛋白聚集的细胞和分子机制尚不完全清楚。最近的证据表明,金属离子诱导的氧化应激和翻译后修饰,如磷酸化、泛素化、硝化、糖化和 SUMO 化,影响α-突触核蛋白的构象及其聚集倾向和神经毒性特征。此外,α-突触核蛋白被特定蛋白酶的蛋白水解切割会导致形成一系列片段,这些片段具有连续改变的、不完全了解的生理和/或病理特性。在本综述中,我们总结了神经丝氨酸、钙蛋白酶-1、组织蛋白酶 D 和基质金属蛋白酶-3 在健康和疾病状态下对α-突触核蛋白的蛋白水解切割的最新认识。我们还阐明了相同酶对阿尔茨海默病中致病性蛋白蛋白水解加工的贡献,并报告了致病性蛋白聚集的潜在跨疾病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feac/8196865/67fa7c56fce2/ijms-22-05450-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feac/8196865/67fa7c56fce2/ijms-22-05450-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feac/8196865/67fa7c56fce2/ijms-22-05450-g001.jpg

相似文献

1
Proteolytic α-Synuclein Cleavage in Health and Disease.健康与疾病中的α-突触核蛋白蛋白水解。
Int J Mol Sci. 2021 May 21;22(11):5450. doi: 10.3390/ijms22115450.
2
A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies.在人类神经核蛋白病中鉴定出一种谷氨酰胺环化酶催化的α-突触核蛋白修饰。
Acta Neuropathol. 2021 Sep;142(3):399-421. doi: 10.1007/s00401-021-02349-5. Epub 2021 Jul 26.
3
Alpha-Synuclein Nitration and Its Implications in Parkinson's Disease.α-突触核蛋白硝化及其在帕金森病中的意义。
ACS Chem Neurosci. 2019 Feb 20;10(2):777-782. doi: 10.1021/acschemneuro.8b00288. Epub 2018 Sep 17.
4
Truncation or proteolysis of α-synuclein in Parkinsonism.帕金森病中α-突触核蛋白的截断或蛋白水解。
Ageing Res Rev. 2023 Sep;90:101978. doi: 10.1016/j.arr.2023.101978. Epub 2023 Jun 5.
5
Effects of alpha-synuclein post-translational modifications on metal binding.α-突触核蛋白翻译后修饰对金属结合的影响。
J Neurochem. 2019 Sep;150(5):507-521. doi: 10.1111/jnc.14721. Epub 2019 Jul 9.
6
Proteasome inhibition induces α-synuclein SUMOylation and aggregate formation.蛋白酶体抑制诱导α-突触核蛋白 SUMO 化和聚集体形成。
J Neurol Sci. 2011 Aug 15;307(1-2):157-61. doi: 10.1016/j.jns.2011.04.015. Epub 2011 Jun 8.
7
Extracellular neurosin degrades α-synuclein in cultured cells.细胞外神经丝氨酸蛋白酶降解培养细胞中的α-突触核蛋白。
Neurosci Res. 2010 Aug;67(4):341-6. doi: 10.1016/j.neures.2010.04.008. Epub 2010 Apr 18.
8
Post-translational modification of α-synuclein in Parkinson's disease.帕金森病中α-突触核蛋白的翻译后修饰
Brain Res. 2015 Dec 2;1628(Pt B):247-253. doi: 10.1016/j.brainres.2015.06.002. Epub 2015 Jun 14.
9
Neurotoxic or neuroprotective: Post-translational modifications of α-synuclein at the cross-roads of functions.神经毒性还是神经保护:α-突触核蛋白的翻译后修饰在功能的十字路口。
Biochimie. 2022 Jan;192:38-50. doi: 10.1016/j.biochi.2021.09.012. Epub 2021 Sep 25.
10
Posttranslational Modifications and Clearing of α-Synuclein Aggregates in Yeast.酵母中α-突触核蛋白聚集体的翻译后修饰与清除
Biomolecules. 2015 Apr 23;5(2):617-34. doi: 10.3390/biom5020617.

引用本文的文献

1
Exploring Tau-C, Tau-A, and C1M as biomarkers for Parkinson's disease.探索Tau-C、Tau-A和C1M作为帕金森病的生物标志物。
Front Neurol. 2025 Apr 30;16:1566228. doi: 10.3389/fneur.2025.1566228. eCollection 2025.
2
Synaptic vesicle-omics in mice captures signatures of aging and synucleinopathy.小鼠的突触小泡组学揭示衰老和突触核蛋白病的特征。
Nat Commun. 2025 May 1;16(1):4079. doi: 10.1038/s41467-025-59441-7.
3
Monomers, Dimers, and Oligomers of Pyroglutamate-Modified α-Synuclein Fragments Exhibit Distinct Biophysical Characteristics.

本文引用的文献

1
Challenges in the diagnosis of Parkinson's disease.帕金森病诊断中的挑战。
Lancet Neurol. 2021 May;20(5):385-397. doi: 10.1016/S1474-4422(21)00030-2.
2
Parkinson's disease.帕金森病。
Lancet. 2021 Jun 12;397(10291):2284-2303. doi: 10.1016/S0140-6736(21)00218-X. Epub 2021 Apr 10.
3
Detection of Dermal Alpha-Synuclein Deposits as a Biomarker for Parkinson's Disease.检测皮肤 α-突触核蛋白沉积作为帕金森病的生物标志物。
焦谷氨酸修饰的α-突触核蛋白片段的单体、二聚体和寡聚体表现出不同的生物物理特性。
ACS Chem Neurosci. 2025 May 21;16(10):1919-1936. doi: 10.1021/acschemneuro.5c00106. Epub 2025 Apr 30.
4
Downregulation of Protease Cathepsin D and Upregulation of Pathologic α-Synuclein Mediate Paucity of DNAJC6-Induced Degeneration of Dopaminergic Neurons.蛋白酶组织蛋白酶 D 的下调和病理性 α-突触核蛋白的上调介导了 DNAJC6 诱导的多巴胺能神经元缺失。
Int J Mol Sci. 2024 Jun 18;25(12):6711. doi: 10.3390/ijms25126711.
5
Polymorphic USP8 allele promotes Parkinson's disease by inducing the accumulation of α-synuclein through deubiquitination.多态性 USP8 等位基因通过去泛素化诱导α-突触核蛋白积累促进帕金森病。
Cell Mol Life Sci. 2023 Nov 19;80(12):363. doi: 10.1007/s00018-023-05006-0.
6
Toll-like Receptor 4 Is Upregulated in Parkinson's Disease Patients and Co-Localizes with pSer129αSyn: A Possible Link with the Pathology.Toll 样受体 4 在帕金森病患者中上调并与 pSer129αSyn 共定位:与病理学的可能联系。
Cells. 2023 May 11;12(10):1368. doi: 10.3390/cells12101368.
7
Neurobiology of Parkinson's Disease.帕金森病的神经生物学。
Int J Mol Sci. 2023 Jun 9;24(12):9933. doi: 10.3390/ijms24129933.
8
Intrathecal Pseudodelivery of Drugs in the Therapy of Neurodegenerative Diseases: Rationale, Basis and Potential Applications.鞘内假性给药在神经退行性疾病治疗中的应用:原理、基础及潜在应用
Pharmaceutics. 2023 Feb 25;15(3):768. doi: 10.3390/pharmaceutics15030768.
9
Calpain-mediated proteolysis as driver and modulator of polyglutamine toxicity.钙蛋白酶介导的蛋白水解作为多聚谷氨酰胺毒性的驱动因素和调节因子。
Front Mol Neurosci. 2022 Oct 19;15:1020104. doi: 10.3389/fnmol.2022.1020104. eCollection 2022.
10
Immunohistochemical Demonstration of the pGlu79 α-Synuclein Fragment in Alzheimer's Disease and Its Tg2576 Mouse Model.免疫组化法检测阿尔茨海默病及其转基因小鼠模型中 pGlu79 α-突触核蛋白片段。
Biomolecules. 2022 Jul 20;12(7):1006. doi: 10.3390/biom12071006.
J Parkinsons Dis. 2021;11(3):937-947. doi: 10.3233/JPD-202489.
4
Cathepsin D Variants Associated With Neurodegenerative Diseases Show Dysregulated Functionality and Modified α-Synuclein Degradation Properties.与神经退行性疾病相关的组织蛋白酶D变体表现出功能失调和α-突触核蛋白降解特性改变。
Front Cell Dev Biol. 2021 Feb 11;9:581805. doi: 10.3389/fcell.2021.581805. eCollection 2021.
5
Cathepsin D: A Candidate Link between Amyloid β-protein and Tauopathy in Alzheimer Disease.组织蛋白酶D:阿尔茨海默病中淀粉样β蛋白与tau蛋白病之间的潜在联系
J Exp Neurol. 2021;2(1):10-15.
6
Heterogeneity in α-synuclein fibril activity correlates to disease phenotypes in Lewy body dementia.α-突触核蛋白纤维活性的异质性与路易体痴呆的疾病表型相关。
Acta Neuropathol. 2021 Apr;141(4):547-564. doi: 10.1007/s00401-021-02288-1. Epub 2021 Feb 28.
7
Identification of Cathepsin D as a Plasma Biomarker for Alzheimer's Disease.鉴定组织蛋白酶 D 作为阿尔茨海默病的血浆生物标志物。
Cells. 2021 Jan 12;10(1):138. doi: 10.3390/cells10010138.
8
Reverse engineering Lewy bodies: how far have we come and how far can we go?反向工程路易体:我们已经走了多远,还能走多远?
Nat Rev Neurosci. 2021 Feb;22(2):111-131. doi: 10.1038/s41583-020-00416-6. Epub 2021 Jan 11.
9
Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities.泛素信号在神经退行性疾病中的作用:机制与治疗机遇。
Cell Death Differ. 2021 Feb;28(2):570-590. doi: 10.1038/s41418-020-00706-7. Epub 2021 Jan 7.
10
Toxic Metamorphosis-How Changes from Lysosomal to Cytosolic pH Modify the Alpha-Synuclein Aggregation Pattern.毒性转化:溶酶体到细胞质 pH 变化如何改变α-突触核蛋白聚集模式。
Biomacromolecules. 2020 Dec 14;21(12):4673-4684. doi: 10.1021/acs.biomac.0c00629. Epub 2020 Oct 13.